Ontology highlight
ABSTRACT: Background
Dupilumab was equally effective among all racial subgroups in clinical trials, but a direct comparison in daily practice is lacking.Objectives
To investigate the effectiveness of dupilumab in patients with atopic dermatitis (AD) in the Netherlands and Japan over 80 weeks of treatment.Methods
A longitudinal comparative cohort study was conducted in patients with AD who were treated with dupilumab in daily practice. We used linear mixed-effects models to determine changes over time.Results
We found statistically significant differences in sex, disease onset, body mass index and therapeutic history between Dutch (n = 208) and Japanese (n = 153) patients. The baseline Eczema Area and Severity Index (EASI) score was higher in Japanese patients (23·8 vs
SUBMITTER: de Wijs LEM
PROVIDER: S-EPMC8453550 | biostudies-literature | 2021 Sep
REPOSITORIES: biostudies-literature